Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 13/20 | 0.47 |
| ▸ | NOS3 | P29474 | 3/20 | 0.37 |
| ▸ | NOS2 | P35228 | 3/20 | 0.37 |
| ▸ | CES1 | P23141 | 1/20 | 0.37 |
| ▸ | HTR2C | P28335 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6101157 | 0.80 | HTR2C (0.39) | ACHENOS2CES1HTR2C | |
| SCHEMBL15606100 | 0.73 | HTR2C (0.39) | NOS3NOS2CES1HTR2C | |
| SCHEMBL16886968 | 0.73 | HTR2C (0.39) | NOS3NOS2CES1HTR2C | |
| SCHEMBL11675005 | 0.73 | EDNRB (0.40) | ACHENOS3NOS2 | |
| SCHEMBL9865315 | 0.71 | USP2 (0.44) | NOS3NOS2 | |
| SCHEMBL817973 | 0.69 | ACHE (0.46) | ACHENOS3NOS2CES1 | |
| SCHEMBL14025921 | 0.69 | — | — | |
| SCHEMBL8349907 | 0.69 | — | — | |
| SCHEMBL30973421 | 0.68 | NOS3 (0.33) | NOS3NOS2CES1HTR2C | |
| SCHEMBL817816 | 0.68 | ACHE (0.44) | ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2905285-B1 | TRANSITION METAL COMPOUND HAVING HETEROATOM, A CATALYST COMPOSITION COMPRISING SAME, AND METHOD FOR PREPARING POLYMER USING SAME | LG CHEMICAL LTD (KR) | 2017-04-05 | — | — | EP | disclosed |
| US-9359388-B2 | Transition metal compound having heteroatom, catalystic composition including the same, and method for preparing polymers using the same | LG CHEM, LTD. (KR) | 2016-06-07 | — | — | US | disclosed |
| US-9359388-B2 | Transition metal compound having heteroatom, catalystic composition including the same, and method for preparing polymers using the same | LG CHEM, LTD. (KR) | 2016-06-07 | — | — | US | disclosed |
| US-20150239916-A1 | TRANSITION METAL COMPOUND HAVING HETEROATOM, CATALYSTIC COMPOSITION INCLUDING THE SAME, AND METHOD FOR PREPARING POLYMERS USING THE SAME | LG CHEM, LTD. (KR) | 2015-08-27 | — | — | US | disclosed |
| US-20150239916-A1 | TRANSITION METAL COMPOUND HAVING HETEROATOM, CATALYSTIC COMPOSITION INCLUDING THE SAME, AND METHOD FOR PREPARING POLYMERS USING THE SAME | LG CHEM, LTD. (KR) | 2015-08-27 | — | — | US | disclosed |
| EP-2905285-A1 | TRANSITION METAL COMPOUND HAVING HETEROATOM, A CATALYST COMPOSITION COMPRISING SAME, AND METHOD FOR PREPARING POLYMER USING SAME | LG Chem, Ltd. (KR) | 2015-08-12 | — | — | EP | disclosed |
| US-4992090-A | Herbicidally active 5,6-dihydrocyclopentathiophenyl-imidazole derivatives | CIBA-GEIGY CORPORATION (US) | 1991-02-12 | — | — | US | disclosed |
| EP-0347378-A1 | Imidazole derivatives | CIBA-GEIGY AG (CH) | 1989-12-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150239916-A1 | TRANSITION METAL COMPOUND HAVING HETEROATOM, CATALYSTIC COMPOSITION INCLUDING THE SAME, AND METHOD FOR PREPARING POLYMERS USING THE SAME | THEM6, TIMCC, PICALM | ACHE 673/4885NOS3 2949/4885NOS2 1374/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.